ArticleScientific reports2023

Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study.

Jing-Xing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.